Many manufacturers seemed to be willing to deal with federal-level central procurement, said state health minister
Odisha health minister Naba Kishore Das wrote to the Union health minister Dr Harsh Vardhan June 1, 2021, seeking the Centre’s help in procuring vaccines against the novel coronavirus disease (COVID-19). He said supply constraints have reduced the immunisation speed in the state over the last month.
The eastern state was vaccinating more than 200,000 people every day in April, Das said. “Now, we are able to vaccinate only 60,000-70,000 people per day even though we have the capacity to vaccinate 300,000 daily.”
Odisha’s vaccine stockpile is fast depleting even as it continues to suffer the second wave of the pandemic. The lack of response from global manufacturers for the state’s vaccine request has aggravated the crisis.
Almost a dozen Indian states and the Mumbai municipal body invited expressions of interests from vaccine makers at a global level. None have reported a favourable response yet; some, including Uttar Pradesh, Punjab, Delhi and Mumbai have officially said that their outreach have come a cropper.
It might be faster and economical if the procurement of global vaccines were made at the “country-level” rather than by individual states. The states, he added, might be given the flexibility to design and decide the distribution of vaccines, taking local factors into consideration.
Odisha was one of the first states in India to go for global tender to procure vaccines on its own.
The state placed an order of 22 million doses of Covishield with Serum Institute of India and 1.03 million doses of Covaxin with Bharat Biotech after the central government allowed the states to procure vaccines directly for the 18-44 age group. The state, however, has got a supply of only 578,480 doses of Covishield and 165,490 doses of Covaxin, according to Das. He added:
Odisha floated global tender for procurement of vaccines looking at the supply problem in direct purchase. There has been limited response to the tender as observed during the pre-bid meetings.
SII and Bharat Biotech International Ltd did not participate in the tender process.
Das noted that many global manufacturers seemed to be willing to deal with federal-level central procurement and require the central government’s statutory clearances for supplying to the states.
In the recent weeks, Odisha has become one of the top five states in India where COVID-19 positive cases are on the rise. The virus spread alarmingly in the rural areas during this wave.
The state consistently recorded more than 10,000 cases throughout the month despite a state-wide lockdown from May 5. The state recorded its highest daily addition of 12,852 cases 17 days into the lockdown.
The daily case growth fell below 10,000 in the last five days. The reduction has been attributed to drop in testing in eight coastal districts that were impacted by Cyclone Yaas on May 26.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.